Connection
Alan Palestine to Incidence
This is a "connection" page, showing publications Alan Palestine has written about Incidence.
|
|
Connection Strength |
|
 |
|
 |
|
0.271 |
|
|
|
-
Huvard MJ, Pecen PE, Palestine AG. The Clinical Characteristics of Noninfectious Occlusive Retinal Vasculitis. Ophthalmol Retina. 2022 01; 6(1):43-48.
Score: 0.121
-
Larochelle MB, Phan R, Craddock J, Abzug MJ, Curtis D, Robinson CC, Giller RH, Cosgrove S, Siringo F, McCourt E, Palestine AG. Cytomegalovirus Retinitis in Pediatric Stem Cell Transplants: Report of a Recent Cluster and the Development of a Screening Protocol. Am J Ophthalmol. 2017 Mar; 175:8-15.
Score: 0.088
-
Reddy AK, Patnaik JL, Miller DC, Lynch AM, Palestine AG, Pantcheva MB. Risk Factors Associated with Persistent Anterior Uveitis after Cataract Surgery. Am J Ophthalmol. 2019 10; 206:82-86.
Score: 0.026
-
McCourt EA, Ying GS, Lynch AM, Palestine AG, Wagner BD, Wymore E, Tomlinson LA, Binenbaum G. Validation of the Colorado Retinopathy of Prematurity Screening Model. JAMA Ophthalmol. 2018 04 01; 136(4):409-416.
Score: 0.024
-
Martin DF, Kuppermann BD, Wolitz RA, Palestine AG, Li H, Robinson CA. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med. 1999 Apr 08; 340(14):1063-70.
Score: 0.007
-
Amital H, Klemperer I, Blank M, Yassur Y, Palestine A, Nussenblatt RB, Shoenfeld Y. Analysis of autoantibodies among patients with primary and secondary uveitis: high incidence in patients with sarcoidosis. Int Arch Allergy Immunol. 1992; 99(1):34-6.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|